Market Segmentation
- Antimicrobial Resistance Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Antimicrobial Resistance Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Resistant Streptococcus Pneumoniae (DRSP)
- Drug Resistant Campylobacter (DRC)
- Clostridium Difficile (CD)
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Drug Resistant Neisseria Gonorrhoeae (DRNG)
- Drug Resistant Salmonella (DRNTS)
- Others
- Antimicrobial Resistance Diagnostics End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Antimicrobial Resistance Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- North America Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- North America Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- U.S.
- U.S. Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- U.S. Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- U.S. Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- U.S. Antimicrobial Resistance Diagnostics Market, By Technology
- Canada
- Canada Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Canada Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Canada Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Canada Antimicrobial Resistance Diagnostics Market, By Technology
- Mexico
- Mexico Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Mexico Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Mexico Antimicrobial Resistance Diagnostics Market, By Technology
- North America Antimicrobial Resistance Diagnostics Market, By Technology
- Europe
- Europe Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Europe Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Europe Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- UK
- UK Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- UK Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- UK Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- UK Antimicrobial Resistance Diagnostics Market, By Technology
- Germany
- Germany Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Germany Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Germany Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Germany Antimicrobial Resistance Diagnostics Market, By Technology
- France
- France Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- France Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- France Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- France Antimicrobial Resistance Diagnostics Market, By Technology
- Italy
- Italy Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Italy Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Italy Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Italy Antimicrobial Resistance Diagnostics Market, By Technology
- Spain
- Spain Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Spain Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Spain Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Spain Antimicrobial Resistance Diagnostics Market, By Technology
- Norway
- Norway Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Norway Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Norway Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Norway Antimicrobial Resistance Diagnostics Market, By Technology
- Denmark
- Denmark Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Denmark Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Denmark Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Denmark Antimicrobial Resistance Diagnostics Market, By Technology
- Sweden
- Sweden Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Sweden Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Sweden Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Sweden Antimicrobial Resistance Diagnostics Market, By Technology
- Europe Antimicrobial Resistance Diagnostics Market, By Technology
- Asia Pacific
- Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Asia Pacific Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Asia Pacific Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Japan
- Japan Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Japan Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Japan Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Japan Antimicrobial Resistance Diagnostics Market, By Technology
- China
- China Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- China Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- China Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- China Antimicrobial Resistance Diagnostics Market, By Technology
- India
- India Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- India Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- India Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- India Antimicrobial Resistance Diagnostics Market, By Technology
- Australia
- Australia Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Australia Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Australia Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Australia Antimicrobial Resistance Diagnostics Market, By Technology
- South Korea
- South Korea Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- South Korea Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- South Korea Antimicrobial Resistance Diagnostics Market, By Technology
- Thailand
- Thailand Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Thailand Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Thailand Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Thailand Antimicrobial Resistance Diagnostics Market, By Technology
- Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology
- Latin America
- Latin America Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Latin America Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Latin America Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Brazil
- Brazil Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Brazil Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Brazil Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Brazil Antimicrobial Resistance Diagnostics Market, By Technology
- Argentina
- Argentina Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Argentina Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Argentina Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Argentina Antimicrobial Resistance Diagnostics Market, By Technology
- Mexico
- Mexico Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Mexico Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Mexico Antimicrobial Resistance Diagnostics Market, By Technology
- Latin America Antimicrobial Resistance Diagnostics Market, By Technology
- Middle East & Africa
- Middle East & Africa Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Middle East & Africa Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Middle East & Africa Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- South Africa
- South Africa Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- South Africa Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- South Africa Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- South Africa Antimicrobial Resistance Diagnostics Market, By Technology
- Saudi Arabia
- Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Saudi Arabia Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology
- UAE
- UAE Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- UAE Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- UAE Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- UAE Antimicrobial Resistance Diagnostics Market, By Technology
- Kuwait
- Kuwait Antimicrobial Resistance Diagnostics Market, By Technology
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
- Kuwait Antimicrobial Resistance Diagnostics Market, By Pathogen
- Drug Resistant Streptococcus Pneumoniae
- Drug Resistant Campylobacter
- Clostridium Difficile
- Drug Resistant Neisseria Gonorrhoeae
- Drug Resistant Salmonella
- Others
- Kuwait Antimicrobial Resistance Diagnostics Market, By End-Use
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Kuwait Antimicrobial Resistance Diagnostics Market, By Technology
- Middle East & Africa Antimicrobial Resistance Diagnostics Market, By Technology
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
